The association between left ventricular mass index and serum sirtuin 3 level in patients with hypertension. Issue 2 (27th August 2020)

• Record Type: Journal Article
• Authors: Karayiğit, Orhan; Çelik, Muhammet Cihat; Kiziltunç, Emrullah; Çiçekçioğlu, Hülya; Topçuoğlu, Canan; Doğanay, Birsen; Çetin, Mustafa
• Is Part Of: Cardiovascular endocrinology & metabolism. Volume 10:Issue 2(2021)
• Page Start: 99
• Page End: 105
• Publication Date: 2020-08-27
• Subjects: hypertension -- left ventricular hypertrophy -- sirtuin; Cardiovascular system -- Diseases -- Periodicals; Endocrine glands -- Diseases -- Periodicals; Endocrinology -- Periodicals; Metabolism -- Disorders -- Periodicals; Diabetes -- Periodicals; 616.1
• DOI: 10.1097/XCE.0000000000000231
• Languages: English
• ISSNs: 2574-0954

Abstract

Abstract : Objectives: Sirtuin 3 (SIRT3) can protect cardiomyocytes from oxidative stress-mediated cell damage and prevent cardiac hypertrophy development. The aim of this study was to evaluate whether a relationship existed between left ventricular mass index (LVMI) and serum SIRT3 levels in patients with hypertension. Patients and methods: This study was conducted as a cross-sectional study of 83 patients between April 2018 and October 2018. The LVMI of all patients was calculated using the formula of the American Echocardiography Association and patients were divided into two groups according to results (increased LVMI and normal LVMI). Results: Increased LVMI was determined in 37.3% of patients, whereas 62.7% had normal LVMI. There was no significant difference between serum SIRT3 levels between those with increased LVMI and normal LVMI (5.8 versus 5.4 ng/ml; P = 0.914). Serum pro-brain natriuretic peptide levels (69 versus 41 ng/ml; P = 0.019) were found to be higher in patients with increased LVMI than in those with normal LVMI. A positive correlation between SIRT3 levels and Sm (myocardial systolic) velocity was also determined ( r = 0.338; P = 0.002). Conclusion: The serum levels of SIRT3, a molecule which has been proposed to have protective properties against myocardial hypertrophy, were not found to be correlated with LVMI values; however, SIRT3 levels were found to be correlated with Sm velocity, which is accepted to be an indicator of myocardial early diastolic dysfunction.